Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced defense systems. As demand accelerates and supply remains heavily concentrated […]

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Targets Supply Gap in Fertilizer for Expanding Organic Food Market

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. As demand for organic food continues to grow across North America, attention is increasingly turning to the upstream inputs required to sustain that expansion. One of the most difficult inputs to scale has been phosphate fertilizer that complies […]

Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Expands Strategy for Critical Magnet Materials Supply

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Securing reliable supplies of specialized rare earth elements is becoming increasingly important as demand rises across defense, energy and advanced manufacturing sectors. With this in mind, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently announced that it is […]

Perpetuals.com Ltd. (NASDAQ: PDC) to Present AI-Driven Trading Platform at Emerging Growth Conference

Perpetuals.com (NASDAQ: PDC), a fintech company developing AI-powered trading products and prediction markets, announced that CEO Patrick Gruhn will deliver a presentation and participate in a live question-and-answer session with investors at the Emerging Growth Conference on April 1 at 12:35 p.m. Eastern Time. The free, online event will provide an overview of the company’s […]

Beeline Holdings Inc. (NASDAQ: BLNE) Reports 127% Revenue Growth and Key Milestones Achieved in Q4 2025, Detailing Strategic Priorities for 2026

Beeline Holdings (NASDAQ: BLNE),  a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, reported strong revenue growth and improving loan economics in its recently reported fourth-quarter 2025 results, highlighting a strategy that combines digital mortgage origination with new fee-based real-estate finance products. The fintech lender posted net revenue of $2.5 million […]

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition

A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development that highlights both the potential of […]

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’

Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators. At the core of its […]

 

From Our Blog

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges

April 2, 2026

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced defense systems. As demand accelerates and supply remains heavily concentrated […]

Rotate your device 90° to view site.